RxDoctor Payments Data

Nicholas Hugentobler, DPM

Foot & Ankle Surgery · Durango, CONPI 1508096116

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (36.5%), education and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Vilex LLC at 34.1% of the total. Reporting peaked in 2021 at $12,436 and has fallen 98.9% since, to $131 in 2025.

$26,095in general payments, 2019–2025

Across 65 payments — averaging $401.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vilex LLC$9K
  • Novastep Inc.$7K
  • In2bones USA, LLC$5K
  • Curvebeam LLC$2K
  • Flower Orthopedics Coporation$2K
  • Organogenesis Inc.$160
  • plus $716 from 12 others
$14,103in research payments, 2019–2025

Across 4 payments — averaging $3525.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ipsen Innovation$9K
  • Bristol Myers Squibb$4K
  • Genentech, Inc.$1K

What the payments were for

  • Royalty or licence$2491%
  • Consulting fees$4,80018%
  • Speaking & faculty fees$9,53437%
  • Travel & lodging$4,11116%
  • Food & beverage$1,3375%
  • Education$6,06423%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,095 in reported general payments places this provider in the 85th percentile of 181 foot & ankle surgery providers in Colorado.

See all foot & ankle surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$7,302,766
Medicare patients
669
Services billed
12,143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban12$4,271
Pregabalin58$1,241
Terbinafine Hcl87$1,138
Gabapentin85$752
Cephalexin125$685
Nitro-BidNitroglycerin13$677
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav60$587
Doxycycline Hyclate41$354
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen35$291
Methylprednisolone48$255
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$210
Cyclobenzaprine Hcl42$202
Meloxicam42$163
Allopurinol19$158
Levofloxacin18$135

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Durango

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →